FTC Approves Johnson & Johnson's $21.3B Acquisition of Synthes

Spine and Orthopedic Devices and Implants

Print
E-mail

FTC Approves Johnson & Johnson's $21.3B Acquisition of Synthes ^Featured

Written by Jaimie Oh | June 12, 2012

Social sharing

The Federal Trade Commission has approved Johnson & Johnson's $21.3 billion acquisition of Synthes but with one stipulation, according to a Washington Post report.

While Johnson & Johnson has been cleared to acquire Synthes, it must sell its wrist fractures unit, known as DVR, to Biomet. The FTC concluded, without this stipulation, Johnson & Johnson and Synthes would control 70 percent of the market for the wrist fracture treatment systems and harm competition.

Channels

Upcoming Becker's Events

2013 ASC and Hospital/Health System Conferences

Spine and Orthopedic Devices and Implants